COSUNTER

Live / Registered — Registered (as of 12 Aug 2025)

What this means for you

Registered since 12 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98731337
Registration number
7887116
Mark type
Stylized text
Filed
03 Sept 2024
Published for opposition
24 Jun 2025
Registered
12 Aug 2025
Attorney of record
Michelle P. Ciotola

Goods and services

  • Class 005 — Pharmaceuticals: Nutritive substances for microorganisms for medical purposes; Medicines made of Chinese traditional medicinal herbs, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Medicinal preparations for human use, the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Drugs for medical purposes, namely, medicaments for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Pharmaceutical preparations, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Crude drugs, namely, medicinal preparations for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Biochemical medicinal preparations for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Medicinal tea; Dietetic foods and beverages adapted for medical use; Dietetic preparations adapted for medical purpose

Owner

Prosecution history

  • 12 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 12 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
  • 24 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 24 Jun 2025 — PUBLISHED FOR OPPOSITION
  • 18 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 21 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 13 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 13 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 13 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 07 Apr 2025 — ASSIGNED TO EXAMINER
  • 21 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 21 Mar 2025 — NON-FINAL ACTION E-MAILED
  • 21 Mar 2025 — NON-FINAL ACTION WRITTEN
  • 06 Mar 2025 — ASSIGNED TO EXAMINER
  • 03 Sept 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

View this trademark record on Marksy